Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 2/20 | 0.31 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.31 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.31 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL135939 | 0.71 | MAPT (0.32) | — | |
| SCHEMBL29365624 | 0.71 | MAPT (0.32) | — | |
| Hydrochloric Acid SCHEMBL2833170 | 0.70 | MAPT (0.32) | — | |
| SCHEMBL29618000 | 0.66 | MAPT (0.32) | MEN1KMT2A | |
| SCHEMBL34469514 | 0.65 | ADRA1D (0.34) | — | |
| SCHEMBL2587303 | 0.65 | ADRA1D (0.34) | — | |
| SCHEMBL3443411 | 0.65 | MAPT (0.32) | MEN1KMT2A | |
| SCHEMBL30084634 | 0.64 | ALDH1A1 (0.36) | ADRA2AADRA2BADRA2CNISCHMEN1 | |
| SCHEMBL23781928 | 0.64 | PLIN1 (0.32) | MEN1KMT2A | |
| SCHEMBL30528337 | 0.63 | ADRA1D (0.34) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100305354-A1 | METHOD FOR THE SYNTHESIS OF DIACIDS OR DIESTERS FROM NATURAL FATTY ACIDS AND/OR ESTERS | ARKEMA FRANCE (FR) | 2010-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100305354-A1 | METHOD FOR THE SYNTHESIS OF DIACIDS OR DIESTERS FROM NATURAL FATTY ACIDS AND/OR ESTERS | FAR1, FADS1, FASN | ADRA2A 1460/4885ADRA2B 2188/4885ADRA2C 749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.